¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"effective membrane resistance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • natural resistance
    ÀÚ¿¬ÀúÇ×
  • osmotic resistance
    »ïÅõ¾ÐÀúÇ×
  • pleiotropic resistance
    1. ´ÙÇ¥ÇöÇü¹ßÇöÀúÇ× 2. ´Ù¾àÁ¦³»¼º
  • progressive resistance
    Á¡ÁõÀúÇ×
  • progressive resistance exercise
    Á¡ÁõÀúÇ׿
  • pulmonary flow resistance
    Æó±â·ùÀúÇ×
  • pulmonary vascular resistance
    ÆóÇ÷°üÀúÇ×
  • peripheral resistance unit
    ¸»ÃÊÀúÇ×´ÜÀ§
  • peripheral vascular resistance
    ¸»ÃÊÇ÷°üÀúÇ×
  • radiation resistance
    ¹æ»ç¼±ÀúÇ×
  • residual resistance
    ÀÜ·ùÀúÇ×
  • resistance
    1. ³»¼º 2. ÀúÇ× 3. ÀúÇ×¼º
  • resistance amplification
    ÀúÇ×ÁõÆø
  • resistance coil
    ÀúÇ×ÄÚÀÏ
  • resistance factor
    ³»¼ºÀÎÀÚ, ÀúÇ×ÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • frictional resistance
    ¸¶ÂûÀúÇ×
  • resistance factor
    ³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
  • resistance furnace
    ÀúÇ×·Î
  • genetic resistance
    À¯ÀüÀúÇ×
  • heterogeneous resistance
    ºñ±ÕÀÏÀúÇ×
  • insulation resistance
    Àý¿¬ÀúÇ×
  • insulin resistance
    Àν¶¸°ÀúÇ×
  • internal resistance
    ³»ºÎÀúÇ×
  • multiple drug resistance
    ´Ù¾àÁ¦³»¼º, ¿©·¯¾àÀúÇ×
  • natural resistance
    ÀÚ¿¬ÀúÇ×
  • one step high level resistance
    ÀÏȸ°íÀúÇ×ȹµæ
  • osmotic resistance
    »ïÅõ¾ÐÀúÇ×
  • peripheral resistance unit
    ¸»ÃÊÀúÇ×´ÜÀ§
  • peripheral vascular resistance
    ¸»ÃÊÇ÷°üÀúÇ×
  • pleiotropic resistance
    ´Ù¸é¹ßÇö¼ºÀúÇ×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Lysosomal membrane
    ¶óÀ̼Ҽظ·(¡­Ø­)
  • POMP (principal outer membrane protein)
    ÁÖ¿ä¿Ü¸·´Ü¹éÁú
  • Reissners membrane
    ¶óÀ̽º³Ê ¸·
  • acid, membrane teichoic
    ¸·¼ºÅ¸ÀÌÄÚ»ê
  • acrosomal membrane
    ÷´Üü¸·
  • amnionic membrane
    ¾ç¸·.
  • anal membrane
    Ç×¹®¸·
  • antebrachial interosseous membrane
    ¾Æ·¡ÆÈ»À»çÀ̸·
  • anterior atlanto-occipital membrane
    ¾ÕȯÃßÈĵθ·, ÀüȯÃßÈĵθ·(îñü» õÐý­Ô騝
  • anterior atlanto-occipital membrane
    ¾Õ°í¸®µÚÅë¼ö¸·
  • anterior hyaloid membrane
    ¾ÕÀ¯¸®Ã¼¸·
  • anterior limiting membrane
    ¾Õ°æ°èÆÇ
  • anterior vitreous membrane
    ¾Õ(Àü)À¯¸®Ã¼¸·
  • artificial membrane
    Àΰø¸·(Àΰø¸·).
  • glassy membrane
    À¯¸®¸·.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • maximal effective dose
    ÃÖ´ëÀ¯È¿·®(õÌÓÞêóüùåÖ).
  • mean effective dose =median e. d.
    50% À¯È¿·®(¡­êóüùåÖ).
  • median effective dose =ED50
    50% À¯È¿·®(¡­êóüùåÖ).
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÀûÁøÅë³óµµ
  • minimal effective dose
    ÃÖ¼ÒÀ¯È¿·®.
  • minimum effective dose
    ÃÖ¼ÒÀ¯È¿·®(¡­êóüùåÖ).
  • minimun effective dose
    ÃÖ¼ÒÀ¯È¿¼±·®
  • optimum effective temperature
    ÃÖÀû°¨°¢¿Âµµ(Ì§ËøË§Ë§Ëí̬).
  • abrasion resistance resin teeth
    ³»¸¶¸ê¼ºÇÕ¼º¼öÁöÄ¡(ұبØþàõùêà÷â§ò·öÍ).
  • acoustic resistance
    À½ÇâÀúÇ×
  • activated protein C resistance
    Ȱ¼ºÈ­C´Ü¹é³»¼º
  • airway resistance
    ±âµµÀúÇ×.
  • airway resistance
    ±âµµÀúÇ×
  • androgen-resistance syndrome
    ³²¼ºÈ£¸£¸ó ³»¼º(ÀúÇ×)ÁõÈıº?
  • antibiotic resistance
    Ç×»ýÁ¦³»¼º
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Proper membrane of semicircular duct
    ¹Ý°í¸®°ü°íÀ¯¸·
    [¿¾ ¿ë¾î] ¹Ý±Ô°ü°íÀ¯¸·
  • Basal membrane of semicircular duct
    ¹Ý°í¸®°ü¹Ù´Ú¸·
    [¿¾ ¿ë¾î] ¹Ý±Ô°ü±âÀú¸·
  • Thyrohyoid membrane
    ¹æÆÐ¸ñ»Ô¸·
    [¿¾ ¿ë¾î] °©»ó¼³°ñ¸·
  • Cloacal membrane
    ¹è¼³°­¸·
    [¿¾ ¿ë¾î] ¹è¼³°­¸·
  • Sternal membrane
    º¹À帷
    [¿¾ ¿ë¾î] Èä°ñ¸·
  • Discontinuous basement membrane
    ºÒ¿¬¼Ó¹Ù´Ú¸·
    [¿¾ ¿ë¾î] ºÒ¿ÏÀü±âÀú¸·
  • Urogenital membrane
    ºñ´¢»ý½Ä¸·
    [¿¾ ¿ë¾î] ¿ä»ý½Ä¸·
  • Mitochondrial membrane
    »ç¸³Ã¼¸·
    [¿¾ ¿ë¾î] »ç¸³Ã¼¸·
  • Epitheliochorial membrane
    »óÇÇÀ¶¸ð¸·
    [¿¾ ¿ë¾î] »óÇÇÀ¶¸ð¸·¼ºÇ÷°£°³À縷
  • Perineal membrane
    »ô¸·
    [¿¾ ¿ë¾î] ȸÀ½¸·
  • Fibrous membrane [Fibrous layer]
    ¼¶À¯¸·
    [¿¾ ¿ë¾î] ¼¶À¯¸·
  • Cell membrane
    ¼¼Æ÷¸·
    [¿¾ ¿ë¾î] ¼¼Æ÷¸·
  • Cellular membrane
    ¼¼Æ÷¼º¸·
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º¸·
  • Internal intercostal membrane
    ¼Ó°¥ºñ»çÀ̸·
    [¿¾ ¿ë¾î] ³»´Á°£¸·
  • Internal intercostal membrane
    ¼Ó°¥ºñ»çÀ̸·
    [¿¾ ¿ë¾î] ³»Ãø°£¸·
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PROM   1) Premature Rupture of Amniotic Membrane; < Labor Onset
  2) Preterm Ruptu...
BLM bilayer lipid membrane; bimolecular liquid membrane; bleomycin; buccolinguomasticatory
BM Bachelor of Medicine; barium meal; basal medium; basal metabolism; basement membrane; basilar membra...
CM California mastitis [test]; calmodulin; capreomycin; carboxymethyl; cardiac murmur; cardiac muscle; ...
EMP electric membrane property; electromagnetic pulse; Embden-Meyerhof pathway; external membrane potent...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MED Minimal effective dose
MEC Minimum effective concentration
VERP Ventricular effective refractory period
BED biological effective dose
M.E.C. minimal effective concentration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • biological membrane
    »ýü ¸·
    ¼¼Æ÷ ¶Ç´Â ¼¼Æ÷ ¼Ò±â°üÀÇ °ÑÀ» ½Î°í ÀÖ´Â ¸·. ¹Ì»ý¹°, ½Ä¹°, µ¿¹°ÀÇ ¼¼Æ÷¸·°ú ¿±·Ïü, ¹ÌÅäÄܵ帮¾ÆÀÇ ³», ¿Ü¸·, °ñÁöü, ¼ÒÆ÷ü ¸·, ÇÙ¸· µîÀÌ º¸±âÀÌ´Ù. »ýü¸·ÀÇ ±¸Á¶¿¡ °üÇÑ ¸ðµ¨Àº ¿©·¯ °¡Áö°¡ Á¦½ÃµÇ¾úÀ¸³ª °áÁ¤ÀûÀÎ °ÍÀº ¾ø´Ù. ¿ª»çÀûÀ¸·Î º¼ ¶§ J.F. ´Ù´Ï¿¤ ¸®°¡ Á¦Ã¢Çϰí J.D. ·Î¹öÆ®½¼¿¡ ÀÇÇØ ¼öÁ¤µÈ ´ÜÀ§¸· ¸ðµ¨ÀÌ ÀÖÀ¸¸ç, ±× ÈÄ B. º¥¼Õ µî¿¡ ÀÇÇØ Á¦Ã¢µÈ ¹Ýº¹ ´ÜÀ§ ¸ðµ¨ÀÌ ÀÖ´Ù. ÇöÀç ³Î¸® ÀÎÁ¤¹Þ°í ÀÖ´Â °ÍÀ¸·Î´Â 1972³â S.J. ½Ì°Å µîÀÌ Á¦Ã¢ÇÑ À¯µ¿ ¸ðÀÚÀÌÅ© ¸ðµ¨ÀÌ ÀÖ´Ù. ¸·ÀÇ ÁÖ ¼ººÐÀº ´Ü¹éÁú°ú ÁöÁúÀÌ¸ç µÎ ¼ººÐÀÇ Áß·®ºñ´Â 3:2~3:1·Î ´Ü¹éÁúÀÌ ¸¹´Ù. ÁöÁúÀÇ ÁÖ ¼ººÐÀº ÀÎÁöÁúÀÌ¸ç »ýü¸·ÀÇ ¼ººÐÀ¸·Î ´Ù´ç·ùµµ ¾à°£ Á¸ÀçÇÑ´Ù. ¸·ÀÇ ±¸¼º ¼ººÐÀÎ ÀÎÁöÁú ºÐÀÚ´Â ÀϺκп¡ Ä£¼ö¼º±â¸¦ °¡Áø °¡´À´Ù¶õ ºÐÀڷμ­, ±× ±ä ÃàÀÌ ¸·¸é°ú Á÷°¢À¸·Î ´Ã¾î¼­ ÀÖ°í ¼Ò¼ö¼º ºÎºÐÀÌ ¸¶ÁÖº¸°í ÀÖ¾î 2ºÐÀÚ µÎ²²ÀÇ ¸·À» ¸¸µç´Ù. ´Ü¹éÁúÀº ÁÖ·Î ±¸»ó ´Ü¹éÁúÀ̸ç, ÀÌ ÁöÁú ÀÌÁßÃþ ¼Ó¿¡ ´Ü¹éÁúÀÇ ¼Ò¼ö¼º ºÎºÐÀÌ Àá°Ü ÀÖµíÀÌ Á¸ÀçÇÑ´Ù. ¾î¶² °ÍÀº ¸·ÀÇ ¾ç¸é¿¡ ºÐÀÚÀÇ ÀϺκÐÀ» µå·¯³»°í ÀÖ´Ù. ÀÌ °á°ú ¸·Àº ÁöÁú°ú ´Ü¹éÁúÀÌ ¸ðÀÚÀÌÅ© »óÀ¸·Î Á¸ÀçÇÏ´Â ±¸Á¶°¡ µÈ´Ù. ÁöÁúÀº »ý¸®Àû ¿Âµµ¿¡¼­´Â ¾×üÀ̱⠶§¹®¿¡ ¸· ¼ººÐÀÎ ´Ü¹éÁúÀº ºñ±³Àû ÀÚÀ¯·Ó°Ô ¸·³»¸¦ À̵¿
  • bowmans membrane
    ¾Õ°æ°èÆÇ
  • bucconasal membrane
    ±¸ºñ¸·
  • buccopharyngeal membrane
    ÇùÀεΠ¸·
  • cell membrane permeability
    ¼¼Æ÷¸· Åõ°ú¼º
  • cellular membrane
    ¼¼Æ÷¼º ¸·
    ¼¼Æ÷ÀÇ Ç¥¸éÀ» µ¤°Å³ª °øµ¿ÀÇ ³»¸éÀ» µ¤´Â, ¶Ç´Â °ø°£À̳ª ±â°üÀ» ³ª´©´Â ¾ãÀº ÃþÀÇ Á¶Á÷.
  • cellulose membrane
    ¼¿·ê·Î½º ¸·
  • chorioallantoic membrane inoculation
    À¶¸ð ¿ä¸· Á¢Á¾
  • circulating antibasement membrane antibody
    ¼øÈ¯ Ç×±âÀú¸· Ç×ü
  • cloacal membrane
    ¹è¼³°­ ¸·, ÃÑ ¹è¼³°­ ¸·
  • decidual membrane
    Å»¶ô¸·
  • demarcation membrane
    ºÐ°è ¸·
  • descemets membrane
    µ¥½º¸Þ ¸·
  • epithelial basement membrane
    »óÇÇ ±âÀú¸·
  • excitable membrane
    ÈïºÐ ¸·
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
cross-resistance <immunology, microbiology> Immunologic resistance to the pathogenic effects of a microorganism because of previous exposure to another species or type having cross reactive antigens.
This phenomenon is seen in microbes that acquire resistance to one drug through direct exposure and turn out to have resistance to one or more other drugs to which it has not been exposed. Cross-resistance arises because the mechanism of resistance to several drugs is the same and arises through the identical genetic mutations.
(09 Oct 1997)
sisomicin-gentamicin resistance ribosomal RNA methylase <enzyme> Catalyses the methylation of 30s ribosomal units to confer sisomicin-gentamicin resistance in micromonospora zionensis
Registry number: EC 2.1.1.-
Synonym: sgm gene product, sgm methylase
(26 Jun 1999)
synaptic resistance The ease or difficulty with which a nerve impulse can cross a synapse.
(05 Mar 2000)
systemic vascular resistance An index of arteriolar compliance or constriction throughout the body; equal to the blood pressure divided by the cardiac output.
(05 Mar 2000)
dicumarol resistance A well-defined autosomal dominant resistance to it, over and above general variability in tolerance to the drug.
(05 Mar 2000)
drug resistance The ability of bacteria and other microorganisms to withstand a drug to which they were once sensitive (and were once stalled or killed outright).
(12 Dec 1998)
drug resistance, microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through plasmids containing resistance factors (r factors).
(12 Dec 1998)
drug resistance, multiple Simultaneous resistance to a broad spectrum of structurally and functionally distinct drugs following exposure to a single agent. It is thought to result from the overexpression of genes encoding an integral plasma membrane protein, p-glycoprotein.
(12 Dec 1998)
drug resistance, neoplasm Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.
(12 Dec 1998)
impact resistance The ability of a lens for eyewear to withstand impact without shattering or breaking, i.e., of a 3/8 -inch steel ball dropped 50 feet; criteria for determination of impact resistance are specified by U.S. Regulations.
(05 Mar 2000)
inductive resistance The weakening of an alternating electric current by passage through a coil of wire or a condenser.
Synonym: inductive resistance.
(05 Mar 2000)
insecticide resistance The development by insects of resistance to insecticide.
(12 Dec 1998)
insulin resistance Many people with noninsulin-dependent diabetes produce enough insulin, but their bodies do not respond to the action of insulin. This may happen because the person is overweight and has too many fat cells, which do not respond well to insulin. Also, as people age, their body cells lose some of the ability to respond to insulin. Insulin resistance is also linked to high blood pressure and high levels of fat in the blood. Another kind of insulin resistance may happen in some people who take insulin injections. They may have to take very high doses of insulin every day (200 units or more) to bring their blood glucose (sugar) down to the normal range.
(09 Oct 1997)
tetracycline resistance Nonsusceptibility of a microbe (usually a bacterium) to the action of tetracycline, which binds to the 30s ribosomal subunit and prevents the normal binding of aminoacyl-trna.
(12 Dec 1998)
thyroid hormone resistance syndrome <syndrome> An inherited syndrome of peripheral resistance to thyroid hormones, transmitted as an autosomal recessive trait, characterised by increased serum concentrations of thyroxine and triiodothyronine, increased thyroid hormone binding ratio, and normal to slightly increased thyroid-stimulating hormone and its response to thyrotropin-releasing hormone. The affected persons are euthyroid to slightly hypothyroid. The absence of hypermetabolism and the presence of possible hypothyroidism indicate the existence of partial resistance to the peripheral action of thyroid hormone.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á